OTC Pharmaceuticals - Brazil

Brazil

In 2024, the revenue in the OTC Pharmaceuticals market in Brazil amounts to BRL US$6,137.00m.
It is projected that the market will experience an annual growth rate of 5.11% from 2024 to 2029.
Among the various markets in the market, the Analgesics market holds the largest market share, with a volume of BRL US$1,407.00m in 2024.
When compared globally, the in the United States generates the highest revenue in the OTC Pharmaceuticals market, reaching BRL US$41,240.00m in 2024.
Taking into account the population figures, the per person revenue in Brazil is estimated to be BRL US$28.20 in 2024.
Looking ahead, it is projected that online sales will contribute approximately 18.38% of the total revenue in the OTC Pharmaceuticals market in Brazil by 2024.
Brazil's OTC Pharmaceuticals market is experiencing a surge in demand for herbal remedies and traditional medicine.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Pharmaceuticals market in Brazil has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.Customer preferences in Brazil have shifted towards self-medication and the use of over-the-counter (OTC) pharmaceuticals. This can be attributed to several factors. Firstly, there is a growing awareness and acceptance of OTC medications among the Brazilian population. Consumers are becoming more knowledgeable about the benefits and safety of these products, and are increasingly comfortable using them for minor ailments and self-care. Additionally, the convenience and accessibility of OTC medications have also played a role in shaping customer preferences. With busy lifestyles and limited access to healthcare professionals, consumers are turning to OTC products as a quick and convenient solution for their healthcare needs.Several trends in the OTC Pharmaceuticals market in Brazil have contributed to its growth. One notable trend is the expansion of product offerings. Manufacturers and retailers have been introducing a wider range of OTC medications to cater to the diverse needs and preferences of consumers. This includes products for different age groups, specific health conditions, and lifestyle choices. Another trend is the increasing availability of OTC medications in pharmacies and supermarkets. This has made these products more accessible to consumers, further driving their demand. Additionally, there has been a growing emphasis on marketing and advertising of OTC medications in Brazil. Manufacturers are investing in promotional activities to raise awareness and educate consumers about the benefits of these products, further fueling their popularity.The OTC Pharmaceuticals market in Brazil is also influenced by local special circumstances. One such circumstance is the country's healthcare system. Brazil has a universal healthcare system, but it faces challenges in terms of access and affordability. This has led to a significant reliance on self-medication and OTC medications among the population. Additionally, Brazil has a large population and a growing middle class, both of which contribute to the demand for OTC pharmaceuticals. As more people have disposable income and access to healthcare, the demand for self-care products is expected to continue to rise.Underlying macroeconomic factors have also played a role in the development of the OTC Pharmaceuticals market in Brazil. The country has experienced steady economic growth in recent years, which has contributed to an increase in disposable income and consumer spending. This has allowed more consumers to afford and purchase OTC medications. Additionally, Brazil has a large and aging population, which has created a growing demand for healthcare products and services. This demographic trend has further fueled the growth of the OTC Pharmaceuticals market.In conclusion, the OTC Pharmaceuticals market in Brazil has been growing due to customer preferences for self-medication, trends in the market such as product expansion and increased availability, local special circumstances like the country's healthcare system, and underlying macroeconomic factors including economic growth and an aging population. This market is expected to continue to expand as consumer awareness and acceptance of OTC medications increases, and as the population's healthcare needs continue to grow.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.